Connection

Anton Dofferhoff to Netherlands

Back to Details
This is a "connection" page, showing publications Anton Dofferhoff has written about Netherlands.
Anton Dofferhoff
Connection Strength
0.164
Netherlands
  1. Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis. PLoS One. 2021; 16(3):e0249231.
    View in: PubMed
    Score: 0.028
  2. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series. Mycoses. 2021 Apr; 64(4):457-464.
    View in: PubMed
    Score: 0.028
  3. Chest CT in the Emergency Department for Diagnosis of COVID-19 Pneumonia: Dutch Experience. Radiology. 2021 02; 298(2):E98-E106.
    View in: PubMed
    Score: 0.028
  4. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infect Dis (Lond). 2021 02; 53(2):102-110.
    View in: PubMed
    Score: 0.028
  5. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Int J Infect Dis. 2020 Dec; 101:283-289.
    View in: PubMed
    Score: 0.027
  6. Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial. Lancet Gastroenterol Hepatol. 2019 04; 4(4):269-277.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.